Previous Article | Next Article 
J Virol, July 1998, p. 5789-5796, Vol. 72, No. 7
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
The Duck Hepatitis B Virus Polymerase Is
Activated by Its RNA Packaging Signal,
John E.
Tavis,*
Brandon
Massey, and
Yunhao
Gong
Department of Molecular Microbiology and
Immunology, St. Louis University School of Medicine, St. Louis,
Missouri 63104
Received 26 February 1998/Accepted 13 April 1998
 |
ABSTRACT |
The
stem-loop at the 5' end of the pregenomic RNA of the
hepatitis B viruses is both the primary element of the RNA packaging signal and the origin of reverse transcription. We have previously presented evidence for a third essential role for
, that of an essential cofactor in the maturation of the viral polymerase (J. E. Tavis and D. Ganem, J. Virol. 70:5741-5750, 1996). In this case, binding of
to the polymerase is proposed to induce a physical alteration to the polymerase that is needed for it to develop enzymatic
activity. Three lines of evidence employing duck
hepatitis B virus supporting this hypothesis are presented here. First, an unusual DNA polymerase activity employing exogenous RNAs (the trans reaction) that was originally discovered with
recombinant duck hepatitis B virus polymerase expressed in
Saccharomyces cerevisiae yeasts was shown to be an
authentic property of the viral polymerase. The trans
reaction was found to be template-dependent reverse transcription of
the exogenous RNA. The trans reaction occurred independently of the hepadnavirus protein-priming mechanism, yet it was
still strongly stimulated by
. This directly demonstrates a role for
in activation of the polymerase. Second, the reverse transcriptase
domain of the polymerase was shown to be physically altered following
binding to
, as would be expected if the alteration was required for
maturation of the polymerase to an enzymatically active form. Finally,
analysis of 15 mutations throughout the duck hepatitis B virus
polymerase demonstrated that the
-dependent alteration to the
polymerase was a prerequisite for DNA priming, reverse transcription,
and the trans reaction.
 |
INTRODUCTION |
The hepatitis B viruses
(hepadnaviruses) are small DNA-containing viruses that replicate by
reverse transcription (reviewed in reference 3). The
interaction between the hepadnavirus polymerase and a stem-loop (
)
at the 5' end of the viral pregenomic RNA is a key event early in
reverse transcription.
is the primary element of the hepadnaviral
RNA packaging signal (6, 7, 11) and is the origin of reverse
transcription (10, 14, 19, 21). Binding between the
polymerase and
is required for RNA packaging. If the complex does
not form, neither the polymerase nor the pregenomic RNA is incorporated
into viral cores (1, 5). The polymerase initiates reverse
transcription within a bulge in
and synthesizes a 3- to
4-nucleotide (nt) minus-strand DNA which is covalently linked to the
polymerase by virtue of the protein-priming mechanism of the
hepadnaviruses (4, 20). This nascent minus-strand DNA is
then transferred from
at the 5' end of the RNA pregenome to a short
region of homology near the 3' end of the RNA prior to further chain
elongation (10, 14, 19, 21).
Using recombinant duck hepatitis B virus (DHBV) polymerase expressed
both in Saccharomyces cerevisiae (TYDP
[16]) and translated in rabbit reticulocyte lysates
(DP [20]), we have presented two lines of evidence
implying that the interaction between the polymerase and
has
another key role early in hepadnavirus reverse transcription; this
interaction also appears to be needed for the polymerase to mature to
an enzymatically active form (18).
The first evidence for a role of
in the maturation of
the polymerase is genetic and was obtained with TYDP
expressed in S. cerevisiae. The key observation was made
with a newly discovered activity of TYDP that synthesizes DNA at the 3'
end of exogenously added RNAs independently of the hepadnavirus protein
priming reaction (the trans activity). TYDP could perform
the trans reaction only when it had been translated in the
presence of
sequences competent to support protein-primed reverse
transcription, despite the fact that the trans reaction does
not employ protein-primed initiation (18). This indicated
that
has an additional role in DNA synthesis beyond being the
origin of reverse transcription. The second line of evidence for a role
for
in the maturation of the polymerase is structural. Translation
of DP in the presence of
sequences competent to support RNA
packaging and DNA synthesis resulted in significantly increased
resistance to proteolysis relative to DP translated in the absence of a
biologically functional
(18). This demonstrated that the
interaction with
induces a structural alteration to the polymerase
prior to its development of enzymatic activity.
These data led to a model in which the polymerase binds to
,
undergoes a reversible alteration, and then becomes active
(18). Here, we present three additional lines of evidence
supporting this maturation model. First, we show that the
trans activity is reverse transcription of the
exogenous RNA and is an authentic property of the DHBV polymerase.
Second, the maturation model predicts that the
-dependent alteration
to the polymerase would somehow affect the reverse transcriptase domain
to activate it. This prediction is fulfilled by mapping the
region of the polymerase that is altered following binding of
to
the reverse transcriptase domain itself. Finally, the
correlation between adoption of the
-dependent altered state
and the development of enzymatic activity of the polymerase is expanded
through analysis of 15 mutant polymerases.
 |
MATERIALS AND METHODS |
DNA constructs and in vitro transcription.
RNAs were
transcribed with Megascript kits (Ambion) according to the
manufacturer's instructions. mRNAs for DHBV polymerase lacking
were transcribed with T7 RNA polymerase from
AflII-linearized pT7DPol. pT7DPol contains DHBV3 (nt 170 to
3021) within pBluescript (Stratagene Cloning Systems); the allele
employed contains a 33-nt insertion at nt 901 encoding the influenza
virus hemagglutinin epitope (8). The mRNAs for the
carboxy-terminal truncations of the polymerase containing 567, 652, 679, or 728 amino acids were produced from pT7DPol truncated at the
BspHI, AseI, SgrAI, and
NcoI sites, respectively.
The plasmid pd
contains the DHBV
coding sequences within
pBluescript (12).
-containing RNAs were transcribed
with T3 RNA polymerase from EcoRV- linearized pd
to produce 172-nt transcripts.
The plasmid pDRF contains DHBV (nt 2401 to 2605) within pBluescript.
Linearization of pDRF with
EcoRI followed by transcription
with T3 RNA polymerase produces a 265-nt positive-polarity RNA
(DRF
+) that does not contain the complete

and
cannot bind to the
DHBV polymerase. Linearization of pDRF with
PstI followed by transcription
with T7 RNA polymerase
produces a 253-nt minus-polarity RNA (DRF

).
D1.5G contains 1.5 copies of DHBV3 (duplication of nt 1658 to 3021) in
pBluescript and produces wild-type DHBV following transfection
into avian cells. The YMHA (D513H/D514A) polymerase-active site
missense mutations were inserted into the 3' copy of the duplication
to
produce the plasmid D1.5G-YMHA.
The plasmid pTYBDP for expression of recombinant DHBV3 polymerase in
S. cerevisiae has been described previously (
17,
19).
The mutant polymerases listed in Table
1 were produced from mutant
derivatives
of pTYBDP and pT7DPol.
Transfection of LMH cells and isolation of viral cores.
LMH
cells (a chicken hepatoma cell line) were transfected by calcium
phosphate coprecipitation as described previously (19). Three days posttransfection, the cells were lysed by the addition of 1 ml of lysis buffer (1 mM Tris [pH 7.5], 1 mM EDTA, 0.25% Nonidet
P-40, 50 mM NaCl, and 8% sucrose). The lysate was brought to 10 mM
CaCl2 and clarified at 13,000 × g for 5 min. The supernatant was treated with 100 U of micrococcal nuclease
(Boehringer Mannheim) at 37°C for 45 min, and digestion was stopped
by the addition of EDTA to 15 mM. The sample was clarified at
13,000 × g for 5 min, and the supernatant was layered
over a 30% sucrose cushion and centrifuged at 245,000 × g for 2 h. The supernatant was discarded, and the
pellet was dissolved in 50 µl of B/EDTA (10 mM HEPES [pH 7.8], 15 mM KCl, 5 mM EDTA) containing 5% sucrose per 100-mm-plate of cells.
Isolation of recombinant virus-like particles.
Virus-like
particles were isolated as described earlier (16), with a
minor modification. S. cerevisiae cultures containing TYDP
expression plasmids were induced by the addition of galactose, and
20 h later cells were lysed. The clarified lysate was layered onto
a two-layer sucrose step gradient (30 and 20%) and centrifuged at
100,000 × g for 3 h. The pellet was suspended in
buffer B/EDTA containing 5% sucrose.
In vitro translation.
35S-labeled DHBV
polymerase was translated in vitro by employing the Rabbit
Reticulocyte Lysate System (Promega) and [35S]methionine
(>1,000 Ci/mMol; Amersham) according to the manufacturer's instructions.
Reverse transcription on exogenous templates (the
trans reaction).
DNA polymerase activity employing
exogenous RNA substrates was detected with recombinant TYDP by
treating 5 µg of protein with 5 U of micrococcal nuclease (Boehringer
Mannheim) and 5 mM CaCl2 at 37°C for 20 min to destroy
the endogenous nucleic acids and then terminating the digestion by the
addition of EGTA to 7.5 mM. The mixture was adjusted to 50 mM Tris (pH
8.0)-100 mM NaCl-0.1% Nonidet P-40-10 mM MgCl2-2.5%
2-mercaptoethanol-4 U of RNasin (Promega)-100 µM each dATP, dCTP,
and dTTP. A total of 2 µCi of [
-32P]dGTP and 1.5 µg of RNA substrate was added, and the reaction mixture was incubated
at 37°C for 1 h. To detect the trans activity within
viral cores, the cores were permeabilized by brief treatment at low pH
(13) prior to the micrococcal nuclease treatment, and DNA
synthesis was measured as described for TYDP. To detect the
trans reaction with in vitro-translated polymerase, DP
translation mixtures were diluted twofold to a final concentration of
50 mM Tris (pH 8.0)-30 mM NaCl-10 mM MgCl2-100 µM each
dATP, dCTP, and dTTP. A total of 2 µCi of [
-32P]dGTP
and 1.5 µg of RNA substrate was added, and the reaction mixtures were
incubated at 37°C for 1 h. In all cases, the nucleic acid
products of the trans reactions were purified by phenol and chloroform extraction, precipitated with ethanol, and resolved by
electrophoresis on denaturing 6% polyacrylamide gels. For Fig. 2C, RNA
in the trans product was hydrolyzed in 250 mM NaOH at 100°C for 15 min and neutralized with HCl prior to loading on the
gel; the NaCl concentration of the untreated sample was balanced with
that of the hydrolyzed sample to correct for potential electrophoretic effects.
Slot blot analysis of the trans reaction.
Target
RNAs (0.1 µg) were transferred to Hybond N (Amersham) membranes and
were cross-linked with UV light. The membranes were blocked at 65°C
in Church buffer (2) for 2 h and then hybridized
overnight at 65°C in the same buffer. Control probes were internally
labeled DRF+ or DRF
RNAs. The
trans product probe was prepared with intracellular DHBV
cores and DRF+ RNA. Following the trans
reaction, the products were purified and the RNA in the sample was
hydrolyzed as described above. The DNA was used as a hybridization
probe overnight at 65°C in Church buffer. All filters were washed at
high stringency: twice in 2× SSC (0.3 M NaCl, 0.03 M sodium citrate
[pH 7.0])-0.1% sodium docecyl sulfate (SDS) for 20 min at 65°C
and then twice in 0.1× SSC-0.1% SDS for 20 min at 65°C.
DNA synthesis by recombinant TYDP.
Reverse transcription by
recombinant TYDP within yeast-derived VLPs has been described
previously (18).
Partial proteolysis of
-polymerase complexes.
Partial
proteolysis of in vitro-translated DP was performed as described
earlier (18).
DNA priming.
DNA priming was detected by a modification of
the conditions described by Wang and Seeger (20). DP was
translated in the presence of
, and then 5 µCi of
[
-32P]dGTP and MgCl2 (to 4 mM) was added.
Samples were incubated at 37°C for 30 min, the reactions were
terminated by addition of Laemmli loading buffer, and the products were
resolved by SDS-polyacrylamide gel electrophoresis (PAGE).
-polymerase binding.
Binding assays were performed as
described by Pollack and Ganem (12).
 |
RESULTS |
The trans reaction is an authentic property of the DHBV
polymerase.
The key observation implying a functional role for
in the maturation of the polymerase was that recombinant TYDP expressed in yeast cells needed to be translated in the presence of
to be
able to synthesize DNA on exogenous RNAs in the trans
reaction, even though
itself was not the substrate (18).
We compared the ability of TYDP with that of native DHBV polymerase
within permeabilized viral cores (VP) and of DP translated in vitro in the presence of
to perform the trans reaction (Fig.
1). The nucleic acids within the viral
cores and translation mixtures were removed with micrococcal nuclease,
and a trans reaction was performed with DRF+
RNA. The products were purified by phenol and chloroform extraction and
resolved on denaturing polyacrylamide gels. DHBV polymerase could
perform the trans reaction regardless of the source of the enzyme (Fig. 1, lanes 2, 4, and 6). In all cases, the YMHA
polymerase-active site missense mutations eliminated DNA synthesis
(lanes 3, 5, and 7). The products ranged in size from a few nucleotides
to approximately the size of the 264-nt substrate RNA. The three polymerases produced very similar sets of products, but with various size distributions. Omission of the permeabilization step with native
viral cores precluded formation of the trans product (data not shown). These data indicate that the ability to perform the trans reaction is an authentic property of the DHBV
polymerase.

View larger version (57K):
[in this window]
[in a new window]
|
FIG. 1.
trans activity is an authentic property of
the DHBV polymerase. DHBV polymerase (expressed in yeast VLPs [TYDP],
in permeabilized native viral cores [VP], or translated in vitro
[DP]) was treated with micrococcal nuclease to degrade the endogenous
nucleic acids and was employed in a trans assay with
DRF+ RNA. The products were purified by phenol and
chloroform extraction prior to resolution on a 6% denaturing
polyacrylamide gel. DRF+ RNA, internally labeled
DRF+ (264 nt); YMHA, the polymerase active-site missense
mutant. The mobilities of single-stranded RNA markers are indicated to
the right.
|
|
The trans reaction is reverse transcription of the
input RNA.
To determine if the trans product was
synthesized in a template-dependent manner, a trans reaction
was performed with the native polymerase, DRF+ RNA, and
dATP, dCTP, dTTP, and [
-32P]dGTP (Fig.
2A, lanes 1 and 2) or with
[
-32P]dGTP alone (lanes 3 and 4). The
trans product was observed with the native polymerase when
all four dNTPs were present but was nearly undetectable in reaction
mixtures containing only [
-32P]dGTP. There was
also a faint signal in reaction mixtures containing the YMHA polymerase
active-site mutant (Fig. 2A, lanes 2 and 4); this product is also
occasionally observed in extracts from mock-transfected cells and hence
is produced by a cellular polymerase (data not shown). These data
indicate that the trans product was probably made by a
template-dependent reaction and not by a terminal-transferase-like reaction. If this were so, the products should have contained sequences derived from the input RNA. Therefore, a trans
reaction was performed with native viral cores and
DRF+ RNA, and the products were purified and
hydrolyzed with NaOH to remove the input RNA. This DNA was used to
probe filter-bound RNAs (Fig. 2B). The trans product
annealed under highly stringent conditions to the DRF+ and
DRF
target RNAs with roughly equal efficiencies but not
to the negative-control luciferase or whole-cell yeast RNAs. This
indicates that the trans product contains specific sequences
derived from the input RNA and that these sequences are of both
polarities. Consistent with the ability of the trans product
to anneal to both positive- and negative-polarity DRF RNAs, the
majority of the trans products were resistant to digestion
with S1 nuclease, indicating that the products are largely double
stranded (data not shown).

View larger version (30K):
[in this window]
[in a new window]
|
FIG. 2.
trans products contain RNA-DNA chimeras
produced by reverse transcription of the input RNA. (A)
trans reaction requires all four dNTPs. Permeabilized DHBV
cytoplasmic cores and DRF+ RNA were employed in the
trans reaction in the presence of dATP, dCTP, dTTP, and
[ -32P]dGTP (lanes 1 and 2) or with
[ -32P]dGTP alone (lanes 3 and 4). VP, wild-type DHBV
polymerase; YMHA, polymerase active-site missense mutant. The
mobilities of the single-stranded RNA markers are indicated to the
left. (B) trans reaction products hybridize specifically to
DRF+ and DRF RNAs. A trans
reaction was performed with permeabilized DHBV viral cores and
DRF+ RNA, and the products were purified with phenol and
chloroform extraction and were subjected to alkaline hydrolysis to
remove any RNA. The RNAs indicated to the left were bound to filters
with a slot blot apparatus. The purified trans product was
used to probe to filter 1, and internally labeled DRF+ and
DRF RNAs were used to probe filters 2 and 3, respectively. The filters were washed at high stringency. (C) The
products of the trans reaction include RNA-DNA chimeras. A
trans reaction was performed with permeabilized DHBV viral
cores and DRF+ RNA, and the products were purified with
phenol and chloroform extraction. Half of the sample was subjected to
alkaline hydrolysis, and half was mock hydrolyzed. The samples were
then resolved by electrophoresis on a 6% denaturing polyacrylamide
gel. The mobilities of the single-stranded RNA size markers are
indicated to the left.
|
|
Other RNAs (DHBV sequences or heterologous sequences) could replace
DRF
+ in the
trans reaction. As before, the
products ranged in size
from a few nucleotides in length to
approximately the size of
the input RNA (data not shown). However, the
trans reaction yielded
no products when the exogenous RNA
was omitted from the reaction
or when DNA oligonucleotides were
substituted for the RNA substrate
(
18; data not
shown).
A
trans reaction was performed with native viral cores and
DRF
+ RNA, and the purified products were subjected to
alkaline hydrolysis
to remove the RNA. Alkaline hydrolysis reduced the
size distribution
of the products. Although it is impossible in this
experiment
to determine the size reduction of an individual molecule,
the
most prominent bands in the hydrolyzed samples are 7 to 35 nt
shorter than are the most prominent bands in the untreated sample
(Fig.
2C). Similar results were observed with the
trans products
produced by TYDP and DP (data not shown). This confirms the previous
observation that a significant proportion of the
trans
product
was an RNA-DNA chimera (
18).
The trans reaction does not involve protein-primed
initiation.
DP, DP-Y96F, and DP-YMHA were translated in vitro in
the presence of
and were employed in DNA priming and
trans reactions. The Y96F mutation removes the tyrosine
hydroxyl that primes DHBV DNA synthesis and hence eliminates
protein-primed initiation and subsequent reverse transcription
(23, 25). DP was active in both the DNA priming and the
trans reactions (Fig. 3A, lanes 4 and 7), whereas Y96F was
active only in the trans reaction (Fig. 3A, lanes 5 and 8). The active-site
missense mutant YMHA was inactive in both assays (lanes 6 and 10). This
indicates that the trans reaction can occur without
protein-primed initiation of reverse transcription.

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 3.
The priming-deficient mutant DP-Y96F is active in the
trans reaction. (A) 35S-labeled DP and DP-Y96F
were translated in vitro in the presence of (lanes 1 to 3) and were
employed in the priming reaction (lanes 4 to 6) or in a
trans reaction with DRF+ (lanes 7 to 9). (B) The
trans reaction is dependent on . DP was translated in
vitro in the presence (lane 1) or absence (lane 2) of prior to use
in the trans reaction. The translation and priming samples
were resolved directly by SDS-PAGE, and the products of the
trans reaction were purified and resolved on a 6%
denaturing polyacrylamide gel. The mobilities of the 89-kDa DP protein
and the single-stranded RNA markers are indicated. Lane 10 contains
32P internally labeled DRF+ RNA.
|
|
DP was then translated in vitro in the presence or absence of

and
was used in a
trans reaction (Fig.
3B). DP was active
in the
trans reaction when translated in the presence of

, but
was 7- to 11-fold less active when translated without

. Therefore,
the
trans activity of the in vitro-translated DP was
strongly
stimulated by

. The residual
trans activity of
DP in the absence
of

is reminiscent of the residual activity
occasionally observed
with DP in the priming assay (see Discussion).
The reverse transcriptase domain of the polymerase is altered upon
binding to
.
Binding to
induces an alteration to the
polymerase that is detected as increased resistance to proteolysis
(18). Our model for the maturation of the polymerase
predicts that this alteration would affect the reverse transcriptase
domain of the polymerase in order to activate it. Therefore, the
boundaries of the fragments of the polymerase protected from
proteolysis were mapped. Figure 4 shows a
diagram of the domains of the polymerase and the sites used to map the
protected region.

View larger version (17K):
[in this window]
[in a new window]
|
FIG. 4.
The -dependent protease-resistant fragments lie
between amino acids 265 and approximately 652. A schematic diagram of
the DHBV polymerase at the top shows the terminal protein (TP), spacer,
reverse transcriptase (RT), and RNase H domains. The amino acid
positions of the boundaries between the domains are indicated above the
diagram, and the locations of the deletions and truncations are
indicated below the diagram. The YMDD polymerase active-site motif is
also shown. The identities of the DP derivatives are indicated to the
left, and the black lines indicate sequences retained within the DP
derivatives. The asterisk indicates the tyrosine-dGMP moiety in DP
following the priming reaction. The degrees of protease resistance
relative to that of the wild-type DP are indicated as follows: +++, 70 to 100%; ++, 10 to 70%; +, 1 to 10%; and , no detectable
activity.
|
|
To determine the amino-terminal boundary of the fragment resistant to
papain digestion, two in-frame deletions were introduced
to DP.
dl79-88 removed 10 amino acids within the terminal protein
domain, and 264 NT removed the 11-amino-acid influenza virus
hemagglutinin
epitope tag found after amino acid 264 (within the spacer
domain)
in our standard DP construct. The deletion derivatives were
translated
in vitro with and without

and were partially digested
with papain,
and the

-dependent resistant fragments were compared to
those
from wild-type DP (Fig.
5A).

protected a
doublet of 36 and 34
kDa from digestion with papain instead of the
single 36-kDa fragment
observed previously (
18). This
doublet is observed with newer
lots of reticulocyte lysate. The two
resistant fragments come
from the same region of the polymerase because
the 36-kDa fragment
is converted to the 34-kDa fragment upon further
digestion (data
not shown). Neither internal deletion of DP affected
the mobilities
of the resistant fragments (lanes 10 to 12), although
the mobilities
of the undigested proteins were altered (lanes 2, 4, and
6). Both
deletion derivatives were enzymatically active in the priming
assay (lanes 13 to 16). These data eliminate amino acids 1 to
264 from
being within the resistant fragments, because the largest
possible
proteolytic fragment of DP in this region that would
be unaffected by
the two deletions is approximately 19 kDa.

View larger version (44K):
[in this window]
[in a new window]
|
FIG. 5.
Amino acids 1 to 264 are not within the -dependent
papain-resistant fragments of DP. (A) 35S-labeled DP and
the internal deletion derivatives dl79-88 and 264 NT were
translated in vitro with or without (lanes 1 to 6) and were
subjected to partial proteolysis with papain (lanes 7 to 12). The
mobilities of the 89-kDa full-length DP and the 36-kDa resistant
fragment are indicated. The DP proteins were also employed in a priming
assay (lanes 13 to 16); translation samples detect the
35S-labeled DP, and priming samples detect
32P-dGMP incorporated during the priming reaction. (B)
Tyrosine 96 is not within the papain- resistant fragments. DP was
translated as described for panel A and employed in a priming assay.
The samples were then split in half and subjected to mock digestion
(lanes 1 to 4) or to partial proteolysis with papain (lanes 5 to 8).
The mobilities of the 89-kDa full-length DP and the 36-kDa protected
fragment are indicated, as is the mobility of the
32P-dGMP-labeled fragment in lane 8 containing Y96. The
isotope detected in each lane is indicated at bottom.
|
|
The exclusion of the amino terminus of the polymerase from the
resistant fragments was confirmed by using the priming assay
to label
tyrosine 96 with [
32P]dGMP prior to partial proteolysis
with papain. DP was translated
in vitro, was allowed to prime DNA
synthesis with [

-
32P]dGTP, and was partially digested
with papain prior to resolution
of the products by SDS-PAGE (Fig.
5B).
The residual
32P-labeled fragment containing Y96 migrated
more rapidly than did
the
35S-labeled protected DP
fragments, eliminating the possibility
that amino acids 1 to 96 are
within the protected fragments.
To map the carboxy-terminal boundary of protease resistant fragments,
DP was translated from truncated mRNAs to produce derivatives
terminating at amino acid 728, 679, 652, or 567. These truncated
proteins were translated in the presence of

and subjected to
partial proteolysis with papain (Fig.
6).
All of the truncated
enzymes were active in the priming assays (lanes
21 to 32). Truncation
of DP at amino acid 728 had no effect on the
resistant fragments
(lane 17). Truncation further to amino acid 679 did
not affect
the mobility of the resistant fragments but did slightly
reduce
the amount of the protected fragments (lane 18). Truncation to
amino acid 652 nearly abolished protection of the fragments and
may
have slightly increased the mobility of the residual protected
fragments (lane 19). Truncation further to amino acid 657 abolished
the
protected fragments (lane 20). These data indicate that amino
acids 679 to 787 are not within the protected fragments and that
the carboxy
terminal boundary of the protected region is likely
to be near amino
acid 652.

View larger version (71K):
[in this window]
[in a new window]
|
FIG. 6.
The carboxy-terminal boundary of the -dependent
papain-resistant fragment lies near amino acid 652. 35S-labeled DP and DP truncated at amino acid 728, 679, 652, or 657 were translated in vitro with or without (lanes 1 to
10) and were subjected to partial proteolysis with papain (lanes 11 to
20). The mobilities of the 89-kDa full-length DP and the 36-kDa
protected fragment are indicated. DP derivatives were also employed in
a priming assay (lanes 21 to 32) as described in the legend to Fig.
5.
|
|
The mapping experiments were repeated with trypsin instead of papain to
probe the structure of DP. Figure
7 shows
partial
proteolysis with trypsin of DP, DP-264 NT, and DP 1-652 (the
derivatives
that define the innermost boundaries of the protected
fragment).
The 40-kDa fragment of DP protected from trypsin
digestion was
affected in exactly the same manner by the modifications
to the
polymerase as was the 36-kDa fragment produced by papain
digestion.

View larger version (48K):
[in this window]
[in a new window]
|
FIG. 7.
protects the same region of DP from digestion with
trypsin as it does with papain. 35S-labeled DP, DP 264 NT,
and DP truncated at amino acid 652 were translated in vitro with or
without (lanes 1 to 4 and 9 to 12) and were subjected to partial
proteolysis with trypsin (lanes 5 to 8 and 13 to 16). The mobilities of
the 89-kDa full-length DP and the 40-kDa protected fragment are
indicated.
|
|
Together, the mapping data summarized in Fig.
4 indicate that the
region of the polymerase protected from partial proteolysis
by papain
and trypsin is essentially the same and that it lies
between amino
acids 265 and approximately 652. This leaves the
carboxy-terminal half
of the spacer domain and the reverse transcriptase
domain as the
potential constituents of the protected fragments.
Mutations to the polymerase support a role for
in the
maturation mechanism.
The correlation between the ability of the
polymerase to adopt the
-dependent protease resistant state and its
development of enzymatic activity was originally established with
wild-type polymerase and mutant
RNAs. To expand this correlation,
15 mutations were introduced throughout the polymerase (Table 1).
Following in vitro translation, the mutant polymerases were assayed for
binding, adoption of the protease-resistant state, DNA priming, and
the trans reaction (priming-independent DNA synthesis). The effects of these mutations on protein-primed reverse transcription by
TYDP expressed in S. cerevisiae were also determined. Five patterns of activity were apparent from these experiments. In the first
pattern, the polymerases possessed all activities (wild-type, F103Y/N104D, K153E, Y156H/D158L, N399D/T400A, D666N, T668V/T670V, H693Y, E696R/L698T, and D715V). In the second pattern, Y96F possessed
-binding activity, protease resistance, and priming-independent DNA
synthesis but could not perform DNA priming or priming-dependent DNA
synthesis. In the third pattern, mutants R404E and YMHA (D513H/D514A) possessed
-binding activity and protease resistance but showed no
DNA priming or DNA synthesis activity. In the fourth pattern, K394L/K395I possessed
-binding activity but exhibited reduced protease resistance and no DNA priming or DNA synthesis. In the final
pattern, the mutants K182E/R183E and F391H/L392D exhibited no activity
in any of the assays. These results support a role for
in
the maturation of the polymerase because the ability to adopt the
-dependent protease-resistant state was a prerequisite for DNA
priming and DNA synthesis in all cases.
 |
DISCUSSION |
The
stem loop at the 5' end of the hepadnavirus pregenomic RNA
was first described as the primary element of the RNA packaging signal
(6, 7, 11). It was subsequently found to be the origin of
reverse transcription (10, 14, 19, 21). In the present
paper, a third fundamental role for
is demonstrated, i.e., that of
an essential cofactor for the maturation of the polymerase to an
enzymatically active form.
We had previously found that TYDP expressed in yeast could
synthesize small amounts of DNA from exogenously added RNAs (the trans reaction [18] [Fig. 3B]).
However, TYDP could perform this reaction only if it had been
translated in the presence of
. This was unexpected because
was
not a substrate in the reaction and
was destroyed prior to the
trans reaction.
The trans reaction has now been shown to be an authentic
property of the DHBV polymerase. The trans reaction itself
is template-dependent reverse transcription of the input RNA
producing DNAs of heterogeneous lengths. Many of these
products contain a small amount of RNA at their 5' ends (Fig. 1 to 3)
(18). This RNA is likely to result from RNA priming of the
reaction, either through transient hybridization of two RNA molecules
or by snap-back priming of a single RNA substrate molecule. The short
length of the RNA portion of the chimera may imply that the RNA is
degraded by an RNase following DNA synthesis. The putative RNase is
likely to be of cellular origin, because a mutant DHBV polymerase
lacking RNase H activity (D715V [24]) produces the
same spectrum of trans products as does the wild-type polymerase (data not shown). Intriguingly, the products of the trans reaction with DRF+ RNA appear to be of
both positive and negative polarity. Because the trans
reaction is eliminated when the DHBV polymerase active site is mutated
(Fig. 1, lanes 3, 5, and 7), synthesis of the first strand in the
trans reaction must be by the viral polymerase. However, the
mechanism of synthesis of the second strand is unknown. Because the
second strand would be made by DNA-dependent DNA polymerization, it
could be produced either by the viral polymerase or by the cellular DNA
polymerases that are also present in the yeast VLP extracts, viral core
preparations, and rabbit reticulocyte lysates.
This analysis of the trans reaction differs from the
previous analysis (18) in two ways. First, the
trans product was found to contain much more DNA than had
been observed earlier. This discrepancy is due at least in part to
improvements in the purification of the polymerases which have reduced
the degradation of the substrate RNA during the reaction and have
increased the efficiency of the trans reaction (unpublished
observations). Second, the speculation that the trans
reaction was a terminal deoxynucleotidyl transferase-like reaction
proved to be inaccurate because the reaction requires all four dNTPs
and because the products hybridize specifically to substrate RNA
sequences. This new evidence does not alter the earlier conclusions
based on the trans reaction.
The importance of the trans reaction for the experiments
reported here is that it allows us to measure DNA synthesis by the polymerase in the absence of protein-primed initiation of reverse transcription. This independence was first shown by the resistance of
the trans product to extraction by phenol (18)
(Fig. 1) and then genetically with the Y96F mutant (Fig. 3).
Importantly, both wild-type DP and DP-Y96F (Fig. 3B and data not shown)
show a strong dependence on a functional
in the trans
reaction. This directly demonstrates that the hepadnavirus polymerase
can synthesize DNA without protein priming and yet still be strongly
influenced by
.
DHBV polymerase amino acids 265 to approximately 652 (essentially the
reverse transcriptase domain) were shown to contain the polymerase
fragments that are protected from proteolysis by papain and trypsin
after binding to
. This region is only slightly bigger than are the
papain and trypsin fragments themselves (about 65 and 30 amino acids
larger, respectively). Therefore, the fragments protected from both
proteases must contain the YMDD polymerase active-site motif at amino
acids 511 to 514. These data do not exclude
-dependent alterations
to other regions of the polymerase; however, there are no data for such
changes at present.
The necessity for formation of the
-dependent structural alteration
to the polymerase prior to its development of DNA priming activity has
now been shown by two independent approaches. Previously, we had
demonstrated that the alteration was a prerequisite for the enzymatic
activity of the wild-type polymerase by employing 14 mutant
sequences (18). Here, this requirement is shown with 15 mutant polymerases and wild-type
(Table 1). Consistent with the
order of events in the proposed maturation mechanism, a mutant
polymerase that bound to
but was deficient in the subsequent stages
of the mechanism (F391H/L392D) was found, and other mutants that were
wild type for
binding and adoption of the protease-resistant state
but that could not progress further to synthesize DNA (R404E and
D513H/D514A [YMHA]) were found. Truncation of the polymerase to
amino acid 567 abolished the protease resistance of the polymerase, and
yet the polymerase retained significant DNA priming activity (Fig. 6).
This discrepancy is likely due to truncation of the polymerase far
enough to expose papain and trypsin sites within the reverse
transcriptase domain that are normally blocked by the deleted portion
of the protein.
The data in the present article and its predecessor (18)
support the hypothesis that the DHBV polymerase is translated in an
inactive form (P) and that it must undergo a posttranslational structural alteration to become active (P*). The alteration to the
polymerase is the essential feature of its maturation from P to P*, and
under physiological conditions the alteration is induced by binding to
. However, there may be other conditions under which the polymerase
may progress to P* (18), because limited DNA synthesis has
been observed by recombinant hepadnavirus polymerases in the absence of
(9, 15, 22). P and P* are interconvertible, because the
protease resistance that is the hallmark of P* is reversible upon
removal of
(18). Perhaps the two forms of the
polymerase are in an equilibrium, with
binding favoring the active
form (Fig. 8, line 1). If there is an
equilibrium between P and P*, the various recombinant systems may vary in their abilities to synthesize DNA in the absence of
because their equilibrium points between the active and the inactive
forms may differ slightly.

View larger version (9K):
[in this window]
[in a new window]
|
FIG. 8.
Posttranslational maturation of the DHBV polymerase. The
polymerase is translated in an inactive state, P, and must undergo an
alteration to reach its active state, P*.
|
|
The role of
in the maturation of the polymerase to P* may be viewed
in two ways. First,
could be required transiently as an RNA
chaperone that helps the polymerase mature properly and then
dissociates from P* (Fig. 8, line 2). Alternatively, the interaction
between the polymerase and
could be required at all times to
maintain P*. In this case, P* would be a ribonucleoprotein complex
(Fig. 8, line 3). If the hepadnavirus polymerase proves to be a
ribonucleoprotein complex, it would imply that there are two RNA
binding sites on the protein, i.e., one for the template and one for
as a structural element of the enzyme. A second copy of
may be required in this case. If so, it would have to be provided
either by a second copy of the pregenomic RNA within the viral cores or
by the 3' copy of
in the pregenomic RNA. Further studies will be
required to establish the full extent of the
-polymerase
interaction.
 |
ACKNOWLEDGMENTS |
We are grateful to Chaomei Liu, Melissa Stevens, and Babatunde
Adeyemo for technical assistance and to Michael Green for critical reading of the manuscript.
This work was supported by NIH grant AI38447, American Cancer Society
grant JFRA-616, and a Young Investigator Matching Grant from the
National Foundation for Infectious Diseases.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Molecular Microbiology and Immunology, St. Louis University
School of Medicine, 1402 S. Grand Blvd., St. Louis, MO 63104. Phone:
(314) 577-8441. Fax: (314) 773-3403. E-mail:
tavisje{at}wpogate.slu.edu.
 |
REFERENCES |
| 1.
|
Bartenschlager, R.,
M. Junker-Niepmann, and H. Schaller.
1990.
The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation.
J. Virol.
64:5324-5332[Abstract/Free Full Text].
|
| 2.
|
Church, G. M., and W. Gilbert.
1984.
Genomic sequencing.
Proc. Natl. Acad. Sci. USA
81:1991-1995[Abstract/Free Full Text].
|
| 3.
|
Ganem, D.
1996.
Hepadnaviridae and their replication, p. 2703-2737.
In
B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa.
|
| 4.
|
Gerlich, W. H., and W. S. Robinson.
1980.
Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand.
Cell
21:801-809[Medline].
|
| 5.
|
Hirsch, R. C.,
J. E. Lavine,
L. J. Chang,
H. E. Varmus, and D. Ganem.
1990.
Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription.
Nature
344:552-555[Medline].
|
| 6.
|
Hirsch, R. C.,
D. D. Loeb,
J. R. Pollack, and D. Ganem.
1991.
cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA.
J. Virol.
65:3309-3316[Abstract/Free Full Text].
|
| 7.
|
Junker-Niepmann, M.,
R. Bartenschlager, and H. Schaller.
1990.
A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA.
EMBO J.
9:3389-3396[Medline].
|
| 8.
|
Kolodziej, P. A., and R. A. Young.
1991.
Epitope tagging and protein surveillance.
Methods Enzymol.
194:508-519[Medline].
|
| 9.
|
Lanford, R. E.,
L. Notvall,
H. Lee, and B. Beams.
1997.
Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase.
J. Virol.
71:2996-3004[Abstract].
|
| 10.
|
Nassal, M., and A. Rieger.
1996.
A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis.
J. Virol.
70:2764-2773[Abstract].
|
| 11.
|
Pollack, J. R., and D. Ganem.
1993.
An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation.
J. Virol.
67:3254-3263[Abstract/Free Full Text].
|
| 12.
|
Pollack, J. R., and D. Ganem.
1994.
Site-specific RNA binding by a hepatitis B virus reverse transcriptase initiates two distinct reactions: RNA packaging and DNA synthesis.
J. Virol.
68:5579-5587[Abstract/Free Full Text].
|
| 13.
|
Radziwill, G.,
H. Zentgraf,
H. Schaller, and V. Bosch.
1988.
The duck hepatitis B virus DNA polymerase is tightly associated with the viral core structure and unable to switch to an exogenous template.
Virology
163:123-132[Medline].
|
| 14.
|
Rieger, A., and M. Nassal.
1996.
Specific hepatitis B virus minus-strand DNA synthesis requires only the 5' encapsidation signal and the 3'-proximal direct repeat DR1*.
J. Virol.
70:585-589[Abstract].
|
| 15.
|
Seifer, M., and D. N. Standring.
1993.
Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1.
J. Virol.
67:4513-4520[Abstract/Free Full Text].
|
| 16.
|
Tavis, J. E., and D. Ganem.
1993.
Expression of functional hepatitis B virus polymerase in yeast reveals it to be the sole viral protein required for correct initiation of reverse transcription.
Proc. Natl. Acad. Sci. USA
90:4107-4111[Abstract/Free Full Text].
|
| 17.
|
Tavis, J. E., and D. Ganem.
1995.
RNA sequences controlling the initiation and transfer of duck hepatitis B virus minus-strand DNA.
J. Virol.
69:4283-4291[Abstract].
|
| 18.
|
Tavis, J. E., and D. Ganem.
1996.
Evidence for the activation of the hepatitis B virus polymerase by binding of its RNA template.
J. Virol.
70:5741-5750[Abstract].
|
| 19.
|
Tavis, J. E.,
S. Perri, and D. Ganem.
1994.
Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer.
J. Virol.
68:3536-3543[Abstract/Free Full Text].
|
| 20.
|
Wang, G.-H., and C. Seeger.
1992.
The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis.
Cell
71:663-670[Medline].
|
| 21.
|
Wang, G.-H., and C. Seeger.
1993.
Novel mechanism for reverse transcription in hepatitis B viruses.
J. Virol.
67:6507-6512[Abstract/Free Full Text].
|
| 22.
|
Wang, G.-H.,
F. Zoulim,
E. H. Leber,
J. Kitson, and C. Seeger.
1994.
Role of RNA in enzymatic activity of the reverse transcriptase of hepatitis B viruses.
J. Virol.
68:8437-8442[Abstract/Free Full Text].
|
| 23.
|
Weber, M.,
V. Bronsema,
H. Bartos,
A. Bosserhoff,
R. Bartenschlager, and H. Schaller.
1994.
Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription.
J. Virol.
68:2994-2999[Abstract/Free Full Text].
|
| 24.
|
Wei, Y.,
J. E. Tavis, and D. Ganem.
1996.
Relationship between viral DNA synthesis and virion envelopment in hepatitis B viruses.
J. Virol.
70:6455-6458[Abstract].
|
| 25.
|
Zoulim, F., and C. Seeger.
1994.
Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase.
J. Virol.
68:6-13[Abstract/Free Full Text].
|
J Virol, July 1998, p. 5789-5796, Vol. 72, No. 7
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Wang, R. Y.-L., Stork, J., Nagy, P. D.
(2009). A Key Role for Heat Shock Protein 70 in the Localization and Insertion of Tombusvirus Replication Proteins to Intracellular Membranes. J. Virol.
83: 3276-3287
[Abstract]
[Full Text]
-
Cao, F., Scougall, C. A., Jilbert, A. R., Tavis, J. E.
(2009). Pre-P Is a Secreted Glycoprotein Encoded as an N-Terminal Extension of the Duck Hepatitis B Virus Polymerase Gene. J. Virol.
83: 1368-1378
[Abstract]
[Full Text]
-
Lin, L., Wan, F., Hu, J.
(2008). Functional and Structural Dynamics of Hepadnavirus Reverse Transcriptase during Protein-Primed Initiation of Reverse Transcription: Effects of Metal Ions. J. Virol.
82: 5703-5714
[Abstract]
[Full Text]
-
Stahl, M., Beck, J., Nassal, M.
(2007). Chaperones Activate Hepadnavirus Reverse Transcriptase by Transiently Exposing a C-Proximal Region in the Terminal Protein Domain That Contributes to {varepsilon} RNA Binding. J. Virol.
81: 13354-13364
[Abstract]
[Full Text]
-
Stahl, M., Retzlaff, M., Nassal, M., Beck, J.
(2007). Chaperone activation of the hepadnaviral reverse transcriptase for template RNA binding is established by the Hsp70 and stimulated by the Hsp90 system. Nucleic Acids Res
35: 6124-6136
[Abstract]
[Full Text]
-
Zhang, Z., Tavis, J. E.
(2006). The Duck Hepatitis B Virus Reverse Transcriptase Functions as a Full-length Monomer. J. Biol. Chem.
281: 35794-35801
[Abstract]
[Full Text]
-
Jacquard, A.-C., Brunelle, M.-N., Pichoud, C., Durantel, D., Carrouee-Durantel, S., Trepo, C., Zoulim, F.
(2006). In Vitro Characterization of the Anti-Hepatitis B Virus Activity and Cross-Resistance Profile of 2',3'-Dideoxy-3'-Fluoroguanosine. Antimicrob. Agents Chemother.
50: 955-961
[Abstract]
[Full Text]
-
Serva, S., Nagy, P. D.
(2006). Proteomics Analysis of the Tombusvirus Replicase: Hsp70 Molecular Chaperone Is Associated with the Replicase and Enhances Viral RNA Replication. J. Virol.
80: 2162-2169
[Abstract]
[Full Text]
-
Cao, F., Badtke, M. P., Metzger, L. M., Yao, E., Adeyemo, B., Gong, Y., Tavis, J. E.
(2005). Identification of an Essential Molecular Contact Point on the Duck Hepatitis B Virus Reverse Transcriptase. J. Virol.
79: 10164-10170
[Abstract]
[Full Text]
-
Panaviene, Z., Panavas, T., Nagy, P. D.
(2005). Role of an Internal and Two 3'-Terminal RNA Elements in Assembly of Tombusvirus Replicase. J. Virol.
79: 10608-10618
[Abstract]
[Full Text]
-
Hu, J., Flores, D., Toft, D., Wang, X., Nguyen, D.
(2004). Requirement of Heat Shock Protein 90 for Human Hepatitis B Virus Reverse Transcriptase Function. J. Virol.
78: 13122-13131
[Abstract]
[Full Text]
-
Cao, F., Tavis, J. E.
(2004). Detection and characterization of cytoplasmic hepatitis B virus reverse transcriptase. J. Gen. Virol.
85: 3353-3360
[Abstract]
[Full Text]
-
Beck, J., Nassal, M.
(2003). Efficient Hsp90-independent in Vitro Activation by Hsc70 and Hsp40 of Duck Hepatitis B Virus Reverse Transcriptase, an Assumed Hsp90 Client Protein. J. Biol. Chem.
278: 36128-36138
[Abstract]
[Full Text]
-
Wang, X., Hu, J.
(2002). Distinct Requirement for Two Stages of Protein-Primed Initiation of Reverse Transcription in Hepadnaviruses. J. Virol.
76: 5857-5865
[Abstract]
[Full Text]
-
Beck, J., Vogel, M., Nassal, M.
(2002). dNTP versus NTP discrimination by phenylalanine 451 in duck hepatitis B virus P protein indicates a common structure of the dNTP-binding pocket with other reverse transcriptases. Nucleic Acids Res
30: 1679-1687
[Abstract]
[Full Text]
-
Beck, J., Nassal, M.
(2001). Reconstitution of a Functional Duck Hepatitis B Virus Replication Initiation Complex from Separate Reverse Transcriptase Domains Expressed in Escherichia coli. J. Virol.
75: 7410-7419
[Abstract]
[Full Text]
-
Hu, J., Anselmo, D.
(2000). In Vitro Reconstitution of a Functional Duck Hepatitis B Virus Reverse Transcriptase: Posttranslational Activation by Hsp90. J. Virol.
74: 11447-11455
[Abstract]
[Full Text]
-
Yao, E., Gong, Y., Chen, N., Tavis, J. E.
(2000). The Majority of Duck Hepatitis B Virus Reverse Transcriptase in Cells Is Nonencapsidated and Is Bound to a Cytoplasmic Structure. J. Virol.
74: 8648-8657
[Abstract]
[Full Text]
-
Gong, Y., Yao, E., Stevens, M., Tavis, J. E.
(2000). Evidence that the first strand-transfer reaction of duck hepatitis B virus reverse transcription requires the polymerase and that strand transfer is not needed for the switch of the polymerase to the elongation mode of DNA synthesis. J. Gen. Virol.
81: 2059-2065
[Abstract]
[Full Text]
-
Lanford, R. E., Kim, Y.-H., Lee, H., Notvall, L., Beames, B.
(1999). Mapping of the Hepatitis B Virus Reverse Transcriptase TP and RT Domains by Transcomplementation for Nucleotide Priming and by Protein-Protein Interaction. J. Virol.
73: 1885-1893
[Abstract]
[Full Text]